Insider · CIK 0001778209
Xin Nakanishi
Files at ONCT (Oncternal Therapeutics, Inc.). First filing -, latest -.
In brief
Xin Nakanishi files SEC Form 4 as director at ONCT (Oncternal Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Xin Nakanishi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 28, 2023 | ONCT Oncternal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2023 |
Questions about Xin Nakanishi
Answered from the filings on this page, as of the latest one.
Is Xin Nakanishi buying or selling?
Xin Nakanishi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Xin Nakanishi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Xin Nakanishi has 0.
Where does Xin Nakanishi file Form 4?
Xin Nakanishi has filed Form 4 at ONCT (Oncternal Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.